/Investor DB

Anthill Ventures — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

Front Range Biosciencesfrontrangebio.cominSep 2017 · $3M

US-focused tissue culture cloning and biotech.

Boulder, US

Christopher Zalewski(Founder)inJonathan Vaught(Founder)inNick Hofmeister(Founder)

Co-investorsKEY Investment PartnersSalveo CapitalSand Hill AngelsAFI Capital PartnersArcadian CapitalHALLEY Venture Partners+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.